The Food and Drug Administration (FDA) has outlined its primary regulatory focus for the fiscal year 2025, spotlighting Laboratory Developed Tests (LDTs), artificial intelligence (AI), and cybersecurity. This strategic roadmap is poised to address the evolving landscape of medical devices, ensuring
Enovacom, a leading developer of software solutions that facilitate seamless data exchange within healthcare organizations, is making significant strides in transforming digital mental health services in the UK. Through their innovative data integration technologies, Enovacom has become a pivotal
Siloton, a health technology firm based in Bristol, has recently raised £860,000 in a successful funding round aimed at advancing the development and commercialization of its groundbreaking eye imaging chip. This notable financial milestone allows the company to transition from research to product
The recent shortage of radioisotopes has sparked an outcry from medical professionals, who are warning about a looming public health crisis. Nuclear medicine is critical to the detection and treatment of various cancers, and hospitals around the UK are concerned about the pressure this will put on
In a landmark resolution that has significant implications for the healthcare IT industry, Carequality, a nonprofit organization facilitating healthcare data exchange, has mediated a contentious dispute between health tech giants Epic and Particle Health. This conflict revolved around the access
The medical technology (MedTech) sector is on the brink of significant growth in mergers and acquisitions (M&A) activity. Despite broader economic uncertainties, several driving forces underscore this anticipated surge. Companies are pivoting towards innovation, leveraging artificial intelligence
The rise in insulin prices has become a heated topic in healthcare discussions, drawing scrutiny towards the roles played by pharmacy benefit managers (PBMs) and pharmaceutical companies. Recently, Texas Attorney General Ken Paxton has taken a significant legal step by suing major PBMs and pharma
During the COVID-19 pandemic, the United States witnessed a profound transformation in the treatment landscape for opioid use disorder (OUD). Due to the urgency of social distancing measures and the heightened demand for accessible healthcare, regulations were adjusted to permit the telehealth
The landscape of cardiovascular diagnostics is undergoing significant transformation, spearheaded by groundbreaking technologies like Elucid's PlaqueIQ. Recently, PlaqueIQ received 510(k) clearance from the Food and Drug Administration (FDA), marking a milestone that promises to enhance how
In recent years, particularly since the onset of the COVID-19 pandemic, telemedicine has fundamentally transformed the landscape of healthcare across Latin America. Healthtech startups have emerged as key players in this transformation, leveraging technology to overcome significant barriers to
